Altimmune

Youtube Subscribe

Open: 2.53 Close: 2.52 Change: -0.01

What an AI can tell you about Altimmune Stock before investing.

This document will help you to evaluate Altimmune without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Altimmune are: Altimmune, announce, Annual, Meeting, oral, presentation, pemvidutide, and the …

Concept Map

Semantic Network

Stock Summary

Altimmune, Inc. focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, is in Phase 2 trial for obesity. It is also developing HepTcell, an immunother.

Today's Summary

Altimmune announces oral presentation of pemvidutide clinical. data at 59th Annual Meeting of European Association for the Study of Diabetes. Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation therapeutics for the treatment of patients with liver diseases and obesity. Altimmune announces completion of dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight. Altimmune Announces Oral Presentation of Clinical Data at 59th Annual Meeting.

Today's News

Altimmune announces oral presentation of pemvidutide clinical. data at 59th Annual Meeting of European Association for the Study of Diabetes. Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation therapeutics for the treatment of patients with liver diseases and obesity. Altimmune announces completion of dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight. Altimmune Announces Oral Presentation of Clinical Data at 59th Annual Meeting.

Stock Profile

"Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland."

Keywords

How much time have you spent trying to decide whether investing in Altimmune? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Altimmune are: Altimmune, announce, Annual, Meeting, oral, presentation, pemvidutide, and the most common words in the summary are: altimmune, best, american, inc, credit, news, market, . One of the sentences in the summary was: Altimmune Announces Oral Presentation of Clinical Data at 59th Annual Meeting.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #altimmune #best #american #inc #credit #news #market.

Read more →

Youtube Subscribe

---